BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27068971)

  • 1. Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins.
    Hay DL; Walker CS; Gingell JJ; Ladds G; Reynolds CA; Poyner DR
    Biochem Soc Trans; 2016 Apr; 44(2):568-73. PubMed ID: 27068971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions of third extracellular loop and helix 8 of Family B GPCRs complexed with RAMPs and characteristics of their receptor trafficking.
    Kuwasako K; Hay DL; Nagata S; Murakami M; Kitamura K; Kato J
    Curr Protein Pept Sci; 2013 Aug; 14(5):416-28. PubMed ID: 23745705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.
    Pioszak AA; Hay DL
    Adv Pharmacol; 2020; 88():115-141. PubMed ID: 32416865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.
    Hay DL; Pioszak AA
    Annu Rev Pharmacol Toxicol; 2016; 56():469-87. PubMed ID: 26514202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.
    Archbold JK; Flanagan JU; Watkins HA; Gingell JJ; Hay DL
    Trends Pharmacol Sci; 2011 Oct; 32(10):591-600. PubMed ID: 21722971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationships of the N-terminus of receptor activity-modifying proteins.
    Qi T; Hay DL
    Br J Pharmacol; 2010 Mar; 159(5):1059-68. PubMed ID: 20015292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
    Moad HE; Pioszak AA
    Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Structure of the CGRP and Related Receptors.
    Simms J; Routledge S; Uddin R; Poyner D
    Handb Exp Pharmacol; 2019; 255():23-36. PubMed ID: 29797088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
    Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
    J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
    Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
    Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAMPs as drug targets.
    Sexton PM; Poyner DR; Simms J; Christopoulos A; Hay DL
    Adv Exp Med Biol; 2012; 744():61-74. PubMed ID: 22434108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.
    Kotliar IB; Lorenzen E; Schwenk JM; Hay DL; Sakmar TP
    Pharmacol Rev; 2023 Jan; 75(1):1-34. PubMed ID: 36757898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor Activity Modifying Proteins Have Limited Effects on the Class B G Protein-Coupled Receptor Calcitonin Receptor-Like Receptor Stalk.
    Garelja ML; Walker CA; Siow A; Yang SH; Harris PWR; Brimble MA; Watkins HA; Gingell JJ; Hay DL
    Biochemistry; 2018 Feb; 57(8):1410-1422. PubMed ID: 29388762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
    Sexton PM; Morfis M; Tilakaratne N; Hay DL; Udawela M; Christopoulos G; Christopoulos A
    Ann N Y Acad Sci; 2006 Jul; 1070():90-104. PubMed ID: 16888151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterodimers and family-B GPCRs: RAMPs, CGRP and adrenomedullin.
    Conner AC; Simms J; Hay DL; Mahmoud K; Howitt SG; Wheatley M; Poyner DR
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):843-6. PubMed ID: 15494030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of GPCR trafficking by RAMPs.
    Bomberger JM; Parameswaran N; Spielman WS
    Adv Exp Med Biol; 2012; 744():25-37. PubMed ID: 22434105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
    Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
    Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of RAMPs upon cell signalling.
    Routledge SJ; Ladds G; Poyner DR
    Mol Cell Endocrinol; 2017 Jul; 449():12-20. PubMed ID: 28390954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [RAMPs and G protein coupled receptors].
    Cueille C; Garel JM
    Med Sci (Paris); 2004; 20(8-9):773-8. PubMed ID: 15361343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.